226 related articles for article (PubMed ID: 16999915)
1. [Use of anabolic androgenic steroids, growth hormone and erythropoietin by patients in general practice].
Keld DB; Hahn T
Ugeskr Laeger; 2006 Sep; 168(37):3121-4. PubMed ID: 16999915
[TBL] [Abstract][Full Text] [Related]
2. [The medical aspect of using anabolic androgenic steroids in males attending gyms of Saint-Petersburg].
Lykhonosov MP; Babenko AY
Probl Endokrinol (Mosk); 2019 May; 65(1):19-30. PubMed ID: 31091047
[TBL] [Abstract][Full Text] [Related]
3. Consequences of use of anabolic androgenic steroids.
Casavant MJ; Blake K; Griffith J; Yates A; Copley LM
Pediatr Clin North Am; 2007 Aug; 54(4):677-90, x. PubMed ID: 17723870
[TBL] [Abstract][Full Text] [Related]
4. [Use of androgenic anabolic steroids before and during the Olympic Games: less but has not died out].
de Ronde W
Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1820-4. PubMed ID: 18783159
[TBL] [Abstract][Full Text] [Related]
5. [Doping and urologic tumors].
Pinto F; Sacco E; Volpe A; Gardi M; Totaro A; Calarco A; Racioppi M; Gulino G; D'Addessi A; Bassi PF
Urologia; 2010; 77(2):92-9. PubMed ID: 20890867
[TBL] [Abstract][Full Text] [Related]
6. MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions.
Nieschlag E; Vorona E
Eur J Endocrinol; 2015 Aug; 173(2):R47-58. PubMed ID: 25805894
[TBL] [Abstract][Full Text] [Related]
7. Anabolic androgenic steroids: a survey of 500 users.
Parkinson AB; Evans NA
Med Sci Sports Exerc; 2006 Apr; 38(4):644-51. PubMed ID: 16679978
[TBL] [Abstract][Full Text] [Related]
8. [Use of testosterone and anabolic androgenic steroids in sport].
Medraś M; Jóźków P
Endokrynol Pol; 2009; 60(3):204-9. PubMed ID: 19569021
[TBL] [Abstract][Full Text] [Related]
9. [Doping preparations use among patients in general practice].
Kjaer M
Ugeskr Laeger; 2006 Sep; 168(37):3107. PubMed ID: 16999911
[No Abstract] [Full Text] [Related]
10. Concomitant abuse of anabolic androgenic steroids and human chorionic gonadotrophin impairs spermatogenesis in power athletes.
Karila T; Hovatta O; Seppälä T
Int J Sports Med; 2004 May; 25(4):257-63. PubMed ID: 15162244
[TBL] [Abstract][Full Text] [Related]
11. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem.
Melnik B; Jansen T; Grabbe S
J Dtsch Dermatol Ges; 2007 Feb; 5(2):110-7. PubMed ID: 17274777
[TBL] [Abstract][Full Text] [Related]
12. Predicting intentions for long-term anabolic-androgenic steroid use among men: a covariance structure model.
Hildebrandt T; Langenbucher J; Carr S; Sanjuan P; Park S
Psychol Addict Behav; 2006 Sep; 20(3):234-40. PubMed ID: 16938061
[TBL] [Abstract][Full Text] [Related]
13. [A case of a tumorsimulating expansion caused by anabolic androgen steroids in body building].
Kienbacher G; Maurer-Ertl W; Glehr M; Feierl G; Leithner A
Sportverletz Sportschaden; 2007 Dec; 21(4):195-8. PubMed ID: 18072080
[TBL] [Abstract][Full Text] [Related]
14. Androgenic-anabolic steroids abuse in males.
Di Luigi L; Romanelli F; Lenzi A
J Endocrinol Invest; 2005; 28(3 Suppl):81-4. PubMed ID: 16042364
[TBL] [Abstract][Full Text] [Related]
15. A race to the starting line.
Vogel G
Science; 2004 Jul; 305(5684):632-5. PubMed ID: 15286358
[No Abstract] [Full Text] [Related]
16. [Anabolic androgenic steroids in amateur sports in the Netherlands].
Woerdeman J; de Hon O; Levi M; de Ronde WP
Ned Tijdschr Geneeskd; 2010; 154():A2004. PubMed ID: 20858322
[TBL] [Abstract][Full Text] [Related]
17. Androgen-androgenic steroids, the athlete, and mortality.
Cotlar MJ
J Insur Med; 2001; 33(3):251-6. PubMed ID: 11558405
[TBL] [Abstract][Full Text] [Related]
18. [Ongoing medical problems in the anti-doping fight].
Delagardelle C; Ries F; Feiereisen P; Urhausen A
Bull Soc Sci Med Grand Duche Luxemb; 2007; (2):109-24. PubMed ID: 18084907
[TBL] [Abstract][Full Text] [Related]
19. Ergogenic aids: a review of basic science, performance, side effects, and status in sports.
Tokish JM; Kocher MS; Hawkins RJ
Am J Sports Med; 2004 Sep; 32(6):1543-53. PubMed ID: 15310585
[TBL] [Abstract][Full Text] [Related]
20. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?
Tentori L; Graziani G
Pharmacol Res; 2007 May; 55(5):359-69. PubMed ID: 17349798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
